PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Ursodeoxycholic acid - Gallstones

PAD Profile : Ursodeoxycholic acid - Gallstones

Brand Names Include :
Destolit, Urdox, Ursofalk, Ursogal, Cholerso

Traffic Light Status

Status 1 of 1.

Status :
Blue
Important
Formulations :
  • Capsules
  • Oral suspension
  • Tablets
Important Information :
Prescribe generically
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

No drugs returned.

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
19 November 2008
Surrey Medicines Commissioners Group
Local acute Trusts requested that ursodeoxycholic acid, used in the treatment of gall stones, is changed from Amber* to green. It was agreed that it should remain Amber* as initiation would still need to be carried out by the hospital Prescribe generically. Note - the branded product Ursofalk 250mg capsules were considered BLACK at the May 2017 PCN

Associated BNF Codes

01. Gastro-Intestinal System
01.09.01. Drugs affecting biliary composition and flow
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More